Medical Condition News

RSS

Study compares the impacts of various race-free equations on kidney disease diagnoses

Equations that estimate individuals' kidney function currently include an adjustment for race. A study appearing in an upcoming issue of JASN compares various race-free equations and their expected impacts on kidney disease diagnoses.

29 Jul 2021

Research finds associations between COVID-19 and persistent cognitive deficits

Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains.

29 Jul 2021

New insights into participation of underrepresented communities in Alzheimer’s clinical trials

A significant hurdle in developing therapeutics and care models for Alzheimer's disease that work for people of all ethnic and racial backgrounds is the recruitment and retention of traditionally underrepresented groups in clinical trials.

29 Jul 2021

Drug combination could make curative surgery possible for some liver cancer patients

A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.

29 Jul 2021

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.

29 Jul 2021

Two new proteins identified as therapeutic targets for preventing NAFLD and associated liver cancer

An international study led by the Lipids&Liver research team at the UPV/EHU-University of the Basque Country, the results of which have recently been published in the prestigious journal Cancer Research, has demonstrated that inhibiting either of the proteins E2F1 or E2F2 in the liver protects against the development of obesity-driven nonalcoholic fatty liver disease and its progression to cancer.

29 Jul 2021

An overview on fitness to drive for patients with cardiovascular diseases

People suffering from various types of cardiovascular disease are subject to a certain accident risk when driving a vehicle on the road. High blood pressure, coronary heart disease and cardiac insufficiency might be grounds for a (temporary) driving ban.

29 Jul 2021

People with chronic pain may find it harder to regulate emotions

More than three million Australians experience chronic pain: an ongoing and often debilitating condition that can last from months to years.

29 Jul 2021

How SARS-CoV-2 variants effect maternal infection and pregnancy

A new study focuses on the impact of SARS-CoV-2 on maternal and perinatal outcomes.

28 Jul 2021

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

Removing a protein that is often overexpressed in a rare and aggressive subtype of leukemia can help to slow the cancer's development and significantly increase the likelihood of survival, according to a study in mice led by scientists at the UCLA Jonsson Comprehensive Cancer Center.

28 Jul 2021

Youth-onset type 2 diabetes is more aggressive and difficult to control, study shows

People with type 2 diabetes diagnosed during youth have a high risk of developing complications at early ages and have a greater chance of multiple complications within 15 years after diagnosis.

28 Jul 2021

People with metabolic syndrome may be at higher risk for second stroke, death

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jul 2021

First interchangeable biosimilar insulin product approved by FDA for treatment of diabetes

Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.

28 Jul 2021

New tool could transform the management of cardiac sarcoidosis patients

Johns Hopkins University scientists have developed a new tool for predicting which patients suffering from a complex inflammatory heart disease are at risk of sudden cardiac arrest.

28 Jul 2021

Natural compound prevents, reverses brain damage linked to Parkinson's disease in mice

Johns Hopkins Medicine researchers say they have added to evidence that the compound farnesol, found naturally in herbs, and berries and other fruits, prevents and reverses brain damage linked to Parkinson's disease in mouse studies.

28 Jul 2021

People with OSA have greater risk of sudden death and cardiovascular conditions

A study by Penn State College of Medicine researchers reveals that people living with obstructive sleep apnea (OSA), a condition that occurs when a person's airway becomes blocked while they are asleep, are twice as likely to experience sudden death compared to people living without OSA.

28 Jul 2021

Improvements in neural learning processes linked to reduced symptoms of depression

Virginia Tech scientists with the Fralin Biomedical Research Institute at VTC have identified neural learning processes to be associated with symptoms of depression and linked improvements in these processes to improved symptoms in research participants being treated for depression.

28 Jul 2021

Nine of ten patients with hypertension do not receive enough treatment

Hypertension (high blood pressure) is the leading treatable cause of illness and death worldwide. More than a billion people are hypertensive, defined as having blood pressure (BP) with a systolic level (the higher number) of at least 140 millimeters of mercury (mmHg) or diastolic level (the lower number) of 90 mmHg or higher.

28 Jul 2021

How do people with post acute sequelae of COVID-19 react to SARS-CoV-2 vaccines?

A new study focuses on the impact of vaccines on the changes in the symptoms in the PASC group.

27 Jul 2021

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

A study analyzes the immune responses of medical personnel, as well as immunocompromised DP and immunosuppressed KTR patients.

27 Jul 2021

Medical Condition News

Study compares the impacts of various race-free equations on kidney disease diagnoses

Research finds associations between COVID-19 and persistent cognitive deficits

New insights into participation of underrepresented communities in Alzheimer’s clinical trials

Drug combination could make curative surgery possible for some liver cancer patients

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Two new proteins identified as therapeutic targets for preventing NAFLD and associated liver cancer

An overview on fitness to drive for patients with cardiovascular diseases

People with chronic pain may find it harder to regulate emotions

How SARS-CoV-2 variants effect maternal infection and pregnancy

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

Youth-onset type 2 diabetes is more aggressive and difficult to control, study shows

People with metabolic syndrome may be at higher risk for second stroke, death

First interchangeable biosimilar insulin product approved by FDA for treatment of diabetes

New tool could transform the management of cardiac sarcoidosis patients

Natural compound prevents, reverses brain damage linked to Parkinson's disease in mice

People with OSA have greater risk of sudden death and cardiovascular conditions

Improvements in neural learning processes linked to reduced symptoms of depression

Nine of ten patients with hypertension do not receive enough treatment

How do people with post acute sequelae of COVID-19 react to SARS-CoV-2 vaccines?

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News